Skip to content
About
About
Join The Team
Pipeline
Technology
Technology
Tavo
VLA
Combination Approach
Publications
Partnering
Resources
Media & Videos
Contact
Menu Toggle
About
Menu Toggle
About
Join The Team
Pipeline
Technology
Menu Toggle
Technology
Tavo
VLA
Combination Approach
Publications
Partnering
Resources
Media & Videos
Contact
PIPELINE
PIPELINE
REGIMEN
TRIAL
INDICATION
PARTNER
PHASE 1
PHASE 2
PIVOTAL
Pipeline
TAVO™
REGIMEN
TAVO™ +
Nivolumab
TRIAL
OMS-104
Phase 2 IST
INDICATION
Neoadjuvant Resectable Locally / Regionally
Advanced Melanoma
PARTNER
PHASE 1
PHASE 2
PIVOTAL
REGIMEN
TAVO™ + Pembrolizumab
TRIAL
Phase 2 RCT
INDICATION
Neoadjuvant Resectable Locally / Regionally
Advanced Melanoma
PARTNER
PHASE 1
PHASE 2
PIVOTAL
REGIMEN
TAVO™ + Pembrolizumab
TRIAL
KEYNOTE-695
INDICATION
Advanced Melanoma
PARTNER
PHASE 1
PHASE 2
PIVOTAL
REGIMEN
TAVO™ + Pembrolizumab
TRIAL
KEYNOTE-890
INDICATION
Advanced Triple Negative
Breast Cancer (TNBC)
PARTNER
PHASE 1
PHASE 2
PIVOTAL
Learn more about our current clinical trials.
LEARN MORE